Cite
MLA Citation
Andrew Hsu et al.. “Clinical activity of 9-ING-41, a small molecule selective glycogen synthase kinase-3 beta (GSK-3β) inhibitor, in refractory adult T-Cell leukemia/lymphoma.” Cancer biology & therapy, vol. 23, no. 1, 2022, pp. 417–423. http://access.bl.uk/ark:/81055/vdc_100159166812.0x000013